FLGT

16.90

0.88% -0.15

Handel nachbörslich: 16.75 -0.15 -0.89%

Fulgent Genetics Inc (FLGT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$17.05

Offen:

$16.9

24-Stunden-Volumen:

306.28K

Relative Volume:

0.80

Marktkapitalisierung:

$520.09M

Einnahmen:

$290.71M

Nettoeinkommen (Verlust:

$-163.43M

KGV:

-3.0839

EPS:

-5.48

Netto-Cashflow:

$11.70M

1W Leistung:

-0.35%

1M Leistung:

+9.39%

6M Leistung:

-22.23%

1J Leistung:

-22.12%

1-Tages-Spanne:

$16.57

$17.19

1-Wochen-Bereich:

$16.51

$17.30

52-Wochen-Spanne:

$14.76

$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Firmenname

Fulgent Genetics Inc

Sektor

Healthcare (1164)

Branche

Diagnostics & Research (59)

Telefon

626-350-0537

Adresse

4399 SANTA ANITA AVE, EL MONTE

Mitarbeiter

Twitter

@FulgentGenetics

Nächster Verdiensttermin

2024-11-08

Neueste SEC-Einreichungen

FLGT's Discussions on Twitter

Vergleichen Sie FLGT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FLGT Fulgent Genetics Inc	16.90	520.09M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	497.60	196.14B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	205.00	150.17B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	419.95	34.36B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	116.98	33.45B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	176.30	31.62B	15.41B	1.37B	2.11B	7.50

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-07	Eingeleitet	UBS	Neutral
2022-12-08	Herabstufung	Piper Sandler	Overweight → Neutral
2022-11-18	Eingeleitet	Raymond James	Outperform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-02-04	Fortgesetzt	Piper Sandler	Overweight
2021-08-05	Fortgesetzt	Credit Suisse	Underperform
2021-01-08	Herabstufung	Credit Suisse	Neutral → Underperform
2020-11-24	Herabstufung	BTIG Research	Buy → Neutral
2020-08-20	Eingeleitet	Oppenheimer	Outperform
2020-05-29	Eingeleitet	BTIG Research	Buy
2019-11-05	Hochstufung	Piper Jaffray	Neutral → Overweight
2018-03-01	Herabstufung	Piper Jaffray	Overweight → Neutral
2017-11-07	Herabstufung	Raymond James	Outperform → Mkt Perform

Alle ansehen

Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten

01:18 AM

Where are the Opportunities in (FLGT) - news.stocktradersdaily.com

01:18 AM

Mar 30, 2025

Charles Schwab Investment Management Inc. Has $3.88 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 30, 2025

Mar 29, 2025

Proficio Capital Partners LLC Purchases New Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 29, 2025

Mar 27, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Intech Investment Management LLC - MarketBeat

Mar 27, 2025

Magnetar Financial LLC Buys Shares of 16,977 Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 27, 2025

Mar 25, 2025

A better buy-in window may exist right now for Fulgent Genetics Inc (FLGT) - SETE News

Mar 25, 2025

Mar 24, 2025

Bank of New York Mellon Corp Sells 38,099 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 24, 2025

Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Purchases 112,011 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Mar 23, 2025

Mar 22, 2025

Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy - Seeking Alpha

Mar 20, 2025

Mar 15, 2025